openPR Logo
Press release

Digital treatment in domestic quarantine in post-Covid syndrome

02-02-2021 04:15 PM CET | Health & Medicine

Press release from: EvoCare Holding AG

Digital EvoCare® treatment at home

Digital EvoCare® treatment at home

Germany - Nuremberg - The largest statutory pension insurance in Europe and UK allows EvoCare. The digital EvoCare® treatment method puts clinics, doctors, and therapists into the position to care for people@home after survival of an infection. Thus, this eHealth method opens the possibility of pandemic-proof care in Corona times.

In the context of post-Covid syndrome, those affected often complain about a wide range of symptoms in both the physical and mental areas. These include chronic fatigue, cough, shortness of breath, muscular weakness, pain, reduced concentration, and memory, and much more. Through targeted treatment, such as respiratory muscle training, medical training therapy, outdoor training or psychological support, these symptoms improve significantly or can disappear completely.

This digital health offer supports patients at home in their own home. Inpatient and outpatient service providers collaborate in applying the care together. They take over the professional and personal therapy supervision, thus ensuring a high quality of treatment. Clinics and practices thus look after their patients in compliance with hygiene measures. According to a medical prescription, patients incur no costs, because the social security system in Germany and Austria have recognized EvoCare® as a billable treatment method.

In 2020, Germany’s “Deutsche Rentenversicherung” integrated EvoCare® into its own treatment offer for its insured people and offers the procedure from its own institutions. This secures workplaces in clinics in times of Covid-19, and employees can also work from home.

With EvoCare®, more than 20 years of experience in digital therapy and telerehabilitation is available. Social security institutions such as the German Pension Insurance (DRV) and Austria, the Pension Insurance Institution (PVA) and BVAEB (Insurance Institution for Public Servants, Railways and Mining) demonstrated the effectiveness and efficiency in scientific studies.

Video
https://youtu.be/Ds51Ai7OC5I

Online presentation
https://sway.office.com/tyrS59UbCmVBtkCr

EvoCare TeleHealth Ltd.
51 Kenilworth Drive, Oadby,
Leicester, LE2 5LT
E-Mail: info@evocare.de
www.digital-health.care

EvoCare Holding AG and EvoCare Telemedizin GmbH are based near Nuremberg in Bavaria. EvoCare TeleHealth Ltd. was founded in UK.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital treatment in domestic quarantine in post-Covid syndrome here

News-ID: 2234931 • Views:

More Releases from EvoCare Holding AG

Digital healthcare start-up EvoCare investors eligible for Federal INVEST grant!
Digital healthcare start-up EvoCare investors eligible for Federal INVEST grant!
Digital Treatment platform EvoCare attested eligible for Federal INVEST grant, rewarding private investors from the European Economic Area with a purchase grant worth 20% of their investment plus tax exemptions. EvoCare, specialist in health care digitalization has been approved by the German Federal Ministry for Economic Affairs and Energy (BMWi) for their “INVEST – Venture Capital Grant”. Founded in 2018, EvoCare is one of Germany’s pioneering digital health care services, working with
EvoCare® granted FDA-similar (DRV*) approval for its digitized EvoCare-Therapy
EvoCare® granted FDA-similar (DRV*) approval for its digitized EvoCare-Therapy
-EvoCare-Therapy can be used for every orthopedic post-surgeries therapy -Approval creates options for patients and surgeons across a broad spectrum of multiple indications -The market potential for EvoCare consists of more than 2.000.000 patients annually in Germany alone -Association of Private Health Insurance Funds signalized cooperation -Health is coming home Nuremberg, Germany – Corporate News: EvoCare Holding AG (the "Company"), specialized in digitized therapy, has announced that the German pension fund (DRV = FDA-similar) has

More Releases for EvoCare®

Punch!® Software Releases Punch!CAD™ SharkCAD® & ViaCAD® 15
NOVATO, Calif., December 10, 2024 - Punch!® Software, a leading software developer of Home Design and CAD titles for over 25 years, today announced the release of new Windows and Mac versions of the SharkCAD® 15 and ViaCAD® 15 family of products. This latest release encompasses a range of variants for the Windows and Macintosh platform: SharkCAD® Pro, SharkCAD®, ViaCAD® Pro, ViaCAD® 2D/3D, and ViaCAD® 2D. Punch!CAD™ products continue to provide innovative
Digital healthcare start-up EvoCare investors eligible for Federal INVEST grant!
Digital Treatment platform EvoCare attested eligible for Federal INVEST grant, rewarding private investors from the European Economic Area with a purchase grant worth 20% of their investment plus tax exemptions. EvoCare, specialist in health care digitalization has been approved by the German Federal Ministry for Economic Affairs and Energy (BMWi) for their “INVEST – Venture Capital Grant”. Founded in 2018, EvoCare is one of Germany’s pioneering digital health care services, working with
Ultimate Chemicals® Featured in Manufacturing Marvels® on The Fox Business Net …
MOORE, OK., Oct. 8, 2021/ -- Ultimate Chemicals® Inc., an integrated manufacturer and supplier of chemicals and related services, is pleased to announce it will be showcased in a broadcast of Manufacturing Marvels® scheduled to air on October 14, 2021 at approximately 9:30-9:44 p.m. EST on The Fox Business Network® (FBN). Ultimate Chemicals has created their products to help restore surfaces to their optimum surface capability. Non-destructive to the surfaces to
Sunera Technologies, Inc Joins SAP® PartnerEdge® Delivering SAP® S/4HANA
Sunera Technologies, Inc Joins SAP® PartnerEdge® Delivering SAP® S/4HANA and Intelligent Enterprise to Manufacturing, Consumer Products, Higher education, and research, Industrial machinery and components, Life sciences and Automotive Industries Chicago, IL, June 10, 2020 – Sunera Technologies, Inc announced that it had joined the SAP® PartnerEdge® program as a Re-sell & Services partner, through which it will resell SAP solutions to midsize organizations in North America. Through this engagement, SuneraTech
Bedpan Washer Disinfectors Market Projections & Growth Status Analyzed during 20 …
Rapid increase in demand for high-performance technology in order to cater to the hygiene care standards is expected to drive the sales of bedpan washer disinfectors. Paramount need for health and occupational safety is anticipated to further drive the demand and sales of bedpan washer disinfectors. Key players and manufacturers in Bedpan Washer Disinfectors Market are taking immense efforts in developing wide-ranging containers, thereby catering to the needs of disinfection
EvoCare® granted FDA-similar (DRV*) approval for its digitized EvoCare-Therapy
-EvoCare-Therapy can be used for every orthopedic post-surgeries therapy -Approval creates options for patients and surgeons across a broad spectrum of multiple indications -The market potential for EvoCare consists of more than 2.000.000 patients annually in Germany alone -Association of Private Health Insurance Funds signalized cooperation -Health is coming home Nuremberg, Germany – Corporate News: EvoCare Holding AG (the "Company"), specialized in digitized therapy, has announced that the German pension fund (DRV = FDA-similar) has